insulin

Mannkind Finally Catches A Break
Seeking Alpha
Tue, 05/19/15 - 10:40 am
MannKind
Afrezza
diabetes
insulin
inhaled insulin
MannKind: Afrezza's slow start due to delays not demand for inhalable insulin
In-Pharma Technologist
Sun, 05/17/15 - 01:33 pm
MannKind
Afrezza
diabetes
insulin
inhaled insulin
Sanofi
Afrezza Users Calling For MannKind To Produce A 2 Unit Cartridge
Seeking Alpha
Wed, 05/6/15 - 07:00 pm
MannKind
diabetes
insulin
Afrezza
inhaled insulin
Afrezza Officially 'Unofficially' Hits $1 Million In Sales
Seeking Alpha
Tue, 05/5/15 - 08:41 am
Afrezza
diabetes
MannKind
Sanofi
insulin
inhaled insulin
Sanofi digs in heels, won't discount Lantus insulin successor Toujeo
BioPharma Dive
Mon, 04/13/15 - 10:30 am
Sanofi
insulin
diabetes
Toujeo
Lantus
Novo Nordisk filing move brings Tresiba closer to U.S. market
Yahoo/Reuters
Thu, 03/26/15 - 09:28 pm
Novo Nordisk
Tresiba
insulin
diabetes
A Look At Afrezza Prescriptions Through Week 6 And Predictions Through Week 10
Seeking Alpha
Mon, 03/16/15 - 10:53 am
Afrezza
MannKind
Sanofi
insulin
diabetes
MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter
TheStreet.com
Mon, 03/2/15 - 09:11 am
MannKind
Afrezza
insulin
diabetes
Sanofi
Lilly's long-acting insulin not ready for prime time
BioPharma Dive
Tue, 02/24/15 - 10:37 am
Eli Lilly
insulin
Peglispro
diabetes
Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro
Yahoo
Mon, 02/23/15 - 09:45 am
Eli Lilly
diabetes
Peglispro
insulin
basal insulin
No MannKind Buyout Until Afrezza Is Profitable
Seeking Alpha
Wed, 02/18/15 - 08:43 am
MannKind
M&A
Afrezza
insulin
diabetes
inhaled insulin
Can Sanofi's kinder, gentler, inhalable Afrezza win reluctant patients over to insulin?
Fierce Pharma Marketing
Wed, 02/4/15 - 10:26 am
Sanofi
Afrezza
inhaled insulin
insulin
diabetes
MannKind
Sanofi SA (ADR) (SNY) Launches Inhaled Insulin Afrezza
Bidness Etc.
Tue, 02/3/15 - 08:59 am
Sanofi
inhaled insulin
Afrezza
diabetes
insulin
drug launches
MannKind
History Suggests MannKind Corporation's Afrezza Could Already Be Doomed
Motley Fool
Fri, 01/9/15 - 08:30 am
MannKind
Afrezza
inhaled insulin
insulin
diabetes
drug pricing
Can MannKind Corporation Stock Soar in 2015?
Motley Fool
Wed, 12/31/14 - 08:54 am
MannKind
Afrezza
insulin
inhaled insulin
Novo Nordisk CEO Speaks Of Short-Term Challenges That Could Limit Growth
Bidness Etc.
Mon, 12/29/14 - 11:03 am
Novo Nordisk
Pharma CEOs
insulin
Tresiba
Lars Sorenson
Eli Lilly agrees to development deal for fast-acting insulin with French drugmaker Adocia
Yahoo/AP
Fri, 12/19/14 - 08:19 am
Eli Lilly
insulin
R&D
diabetes
Adocia
Sanofi U.S. Sales Executive Leaves After Insulin Forecast
Bloomberg
Fri, 12/5/14 - 08:40 am
Sanofi
diabetes
insulin
Will Insulin Pricing Be MannKind Corporation's Downfall?
Motley Fool
Wed, 11/26/14 - 12:11 pm
MannKind
diabetes
insulin
inhaled insulin
Afrezza
drug pricing
Sanofi, MannKind say cutting insulin costs will make Afrezza more competitive
Fierce Pharma Marketing
Wed, 09/17/14 - 05:47 pm
Sanofi
MannKind
insulin
diabetes
Afrezza

Pages